Biomimetic Redox-Responsive Mesoporous Organosilica Nanoparticles Enhance Cisplatin-Based Chemotherapy
Cisplatin-based chemotherapy is dominated in several cancers; however, insufficient therapeutic outcomes and systemic toxicity hamper their clinical applications. Controlled release of cisplatin and reducing inactivation remains an urgent challenge to overcome. Herein, diselenide-bridged mesoporous...
Main Authors: | Fangman Chen, Fan Zhang, Yanbin Wang, Jiahui Peng, Lei Cao, Qian Mei, Mingfeng Ge, Li Li, Meiwan Chen, Wen-fei Dong, Zhimin Chang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-03-01
|
Series: | Frontiers in Bioengineering and Biotechnology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fbioe.2022.860949/full |
Similar Items
-
Periodic Mesoporous Organosilica Nanorice
by: Mohanty Paritosh, et al.
Published: (2008-01-01) -
Mesoporous organosilica nanoparticles: Degradation strategies and application in tumor therapy
by: Lei Guan, et al.
Published: (2021-10-01) -
Biomimetic nanocarriers in cancer therapy: based on intercellular and cell-tumor microenvironment communication
by: He Mengyuan, et al.
Published: (2024-10-01) -
Encapsulation of Upconversion Nanoparticles in Periodic Mesoporous Organosilicas
by: Saher Rahmani, et al.
Published: (2019-11-01) -
Biomimetic, folic acid-modified mesoporous silica nanoparticles with “stealth” and “homing” capabilities for tumor therapy
by: Xianlong Hu, et al.
Published: (2024-05-01)